Proposal aims to build a database of bulk drug traders, improve traceability of imported raw materials, over 70% of which ...

The move would dismantle the existing system under which bulk drugs and finished formulations operate under a common licence ...

Antique expects the Concord to report revenue, Ebitda and PAT CAGR of 18 per cent, 17 per cent and 19 per cent, respectively, ...

Pharmaceutical Isolator Market Size The global Pharmaceutical Isolator market was valued at USD 432 Million in the year 2024 ...

UP govt to discuss Lalitpur bulk drugs park with pharma companies in Telangana on Jan 6: Shardul Nautiyal, Mumbai Tuesday, January 6, 2026, 08:00 Hrs [IST] To boost self-reliance ...

Antique said it expected Concord Biotech to deliver revenue, Ebitda and PAT CAGR of 18 per cent, 17 per cent and 19 per cent, ...

DoP includes member of HTAIn in expert committee on pricing of drugs: Gireesh Babu, New Delhi Friday, January 2, 2026, 08:00 Hrs [IST] Department of Pharmaceuticals (DoP) has adde ...

We are very much confident that we will be able to achieve our guidance of 20 percent plus growth in revenue, Managing ...

Shilpa Medicare has received an ex-parte ad-interim injunction order from the Delhi High Court, restraining the company and ...

China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...

The agenda of the CEOs’ roundtable includes discussions on issues involving captains of industry, industrial trade bodies and ...

Union Health Ministry has decided to ban the manufacture, sale and distribution of all oral formulations of pain and fever medications with immediate effect. The ban includes Nimesulide above 100 ...